TBPH   $9.46  -1.56% Market Closed After Close 9.5 0.42%

Theravance Biopharma Inc
Total Cash 96.08M
totalCashPerShare 1.964
EBITDA -39.17M
Total Debt 46.66M
quickRatio 4.81
currentRatio 5.199
Total Revenue 62.02M
debtToEquity 24.09
Revenue/Share 1.249
ROA -0.06022
ROE -0.19268999
grossProfits
freeCashflow 4.97M
operatingCashflow -8.78M
earningsGrowth
revenueGrowth 0.037
grossMargins 0.42683
ebitdaMargins -0.63168
operatingMargins -0.89463997
profitMargins -0.73614
enterpriseValue 355.17M
forwardPE 137.83334
floatShares 21.17M
sharesOutstanding 48.92M
sharesShort 5.04M
sharesShortPriorMonth 5.36M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.94%
Short Ratio help_outline 24.51%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 3.959
Price To Book help_outline 2.09
earningsQuarterlyGrowth
netIncomeToCommon -45.65M
trailingEps -0.95%
forwardEps 0.06%
enterpriseToEbitda -9.07
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2024
institutionsCount 185
lastUpdated Nov. 6, 2024, 5:26 p.m.